244 related articles for article (PubMed ID: 18948273)
1. Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice.
Gitlin JM; Loftin CD
Cardiovasc Res; 2009 Feb; 81(2):400-7. PubMed ID: 18948273
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
3. The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.
Skarke C; Reus M; Schmidt R; Grundei I; Schuss P; Geisslinger G; Lötsch J
Clin Pharmacol Ther; 2006 Dec; 80(6):621-32. PubMed ID: 17178263
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice.
Burleigh ME; Babaev VR; Yancey PG; Major AS; McCaleb JL; Oates JA; Morrow JD; Fazio S; Linton MF
J Mol Cell Cardiol; 2005 Sep; 39(3):443-52. PubMed ID: 16040051
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib aggravates atherogenesis and upregulates leukotrienes in ApoE
Pang Y; Gan L; Wang X; Su Q; Liang C; He P
Atherosclerosis; 2019 May; 284():50-58. PubMed ID: 30875493
[TBL] [Abstract][Full Text] [Related]
6. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.
King VL; Trivedi DB; Gitlin JM; Loftin CD
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1137-43. PubMed ID: 16514081
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib combined with atorvastatin prevents progression of atherosclerosis.
Raval M; Frank PG; Laury-Kleintop L; Yan G; Lanza-Jacoby S
J Surg Res; 2010 Oct; 163(2):e113-22. PubMed ID: 20538289
[TBL] [Abstract][Full Text] [Related]
8. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
Jacob S; Laury-Kleintop L; Lanza-Jacoby S
J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
[TBL] [Abstract][Full Text] [Related]
9. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice.
Gibson FC; Hong C; Chou HH; Yumoto H; Chen J; Lien E; Wong J; Genco CA
Circulation; 2004 Jun; 109(22):2801-6. PubMed ID: 15123526
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2-dependent prostaglandin production by peripheral blood monocytes stimulated with lipopolysaccharides isolated from periodontopathogenic bacteria.
Noguchi K; Yanai M; Shitashige M; Nishihara T; Ishikawa I
J Periodontol; 2000 Oct; 71(10):1575-82. PubMed ID: 11063390
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta.
Chen YL; Hu CS; Lin FY; Chen YH; Sheu LM; Ku HH; Shiao MS; Chen JW; Lin SJ
J Cell Biochem; 2006 Jun; 98(3):618-31. PubMed ID: 16440326
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice.
Westerterp M; Berbée JF; Pires NM; van Mierlo GJ; Kleemann R; Romijn JA; Havekes LM; Rensen PC
Circulation; 2007 Nov; 116(19):2173-81. PubMed ID: 17967778
[TBL] [Abstract][Full Text] [Related]
13. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein.
Zhou Q; Desta T; Fenton M; Graves DT; Amar S
Infect Immun; 2005 Feb; 73(2):935-43. PubMed ID: 15664935
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2-mediated prostaglandin E2 production in mesenteric lymph nodes and in cultured macrophages and dendritic cells after infection with Salmonella.
Bowman CC; Bost KL
J Immunol; 2004 Feb; 172(4):2469-75. PubMed ID: 14764719
[TBL] [Abstract][Full Text] [Related]
15. In vivo exposure to Porphyromonas gingivalis up-regulates nitric oxide but suppresses tumour necrosis factor-alpha production by cultured macrophages.
Frolov I; Houri-Hadad Y; Soskolne A; Shapira L
Immunology; 1998 Mar; 93(3):323-8. PubMed ID: 9640241
[TBL] [Abstract][Full Text] [Related]
16. Human β-defensin-3 alleviates the progression of atherosclerosis accelerated by Porphyromonas gingivalis lipopolysaccharide.
Li L; Bian T; Lyu J; Cui D; Lei L; Yan F
Int Immunopharmacol; 2016 Sep; 38():204-13. PubMed ID: 27289299
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic celecoxib on testicular function in normal and lipopolysaccharide-treated rats.
Winnall WR; Muir JA; Liew S; Hirst JJ; Meachem SJ; Hedger MP
Int J Androl; 2009 Oct; 32(5):542-55. PubMed ID: 18522674
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery.
Sakai M; Tanebe K; Sasaki Y; Momma K; Yoneda S; Saito S
Mol Hum Reprod; 2001 Jun; 7(6):595-602. PubMed ID: 11385116
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2.
Aid S; Langenbach R; Bosetti F
J Neuroinflammation; 2008 May; 5():17. PubMed ID: 18489773
[TBL] [Abstract][Full Text] [Related]
20. Effect of retinoids on LPS-induced COX-2 expression and COX-2 associated PGE(2) release from mouse peritoneal macrophages and TNF-alpha release from rat peripheral blood mononuclear cells.
Kim BH; Kang KS; Lee YS
Toxicol Lett; 2004 Apr; 150(2):191-201. PubMed ID: 15093674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
